Interleukin-6 blocker for successful outcome of late-onset rheumatoid oligoarthritis

Journal Title: IP International Journal of Orthopaedic Rheumatology - Year 2017, Vol 3, Issue 1

Abstract

Newer cytokine therapies have revolutionised the management of Rheumatoid arthritis. Atypical oligoarthritis can also be a manifestation of RA and CCP antibodies have been proven to be most specific for Rheumatoid. Our patient had 2 years of painful ankle bilaterally and suggested for joint replacement due to osteoarthritis changes. After the diagnosis of RA using Anti-CCP antibodies, we elected to give Tocilizumab(IL 6 Blocker) which had made the patient to walk without wheelchair after 2 years. This suggests early appropriate diagnosis is the key and Biologics- the new Kid in the market- has proven to be effective in early Rheumatoid arthritis.

Authors and Affiliations

Yuva Vishalini Ravindran, Subramanian Nallasivan

Keywords

Related Articles

Management of the displaced intra articular fracture calcaneum by open reduction & internal fixation with the locking calcaneum plate: A study

Introduction Since the midnineties open reduction and internal fixation is considered as the gold standard treatment for the displaced intraarticular fractures of the calcaneus by most experts However there still remains...

Latest recommendation for gout treat –To target

The treat-to-target concept has been applied successfully in several inflammatory rheumatic diseases. Gout is a chronic disease with a high burden of pain and inflammation. The pathogenesis of gout is strongly related to...

Post-operative infection in total knee arthroplasty in steroid dependent rheumatoid arthritis

Background: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease which primarily affects and damages synovial joints. Patients with RA will therefore often undergo joint replacement surgery. Patients wi...

Fibromyalgia syndrome: Unraveling the mystery

Fibromyalgia (FM) is a common chronic widespread pain disorder. Understanding this disease has increased substantially in recent years with extensive research. Neurochemical imbalances in the central nervous system are a...

Download PDF file
  • EP ID EP298455
  • DOI 10.18231/2455-6777 .2017.0007
  • Views 87
  • Downloads 0

How To Cite

Yuva Vishalini Ravindran, Subramanian Nallasivan (2017). Interleukin-6 blocker for successful outcome of late-onset rheumatoid oligoarthritis. IP International Journal of Orthopaedic Rheumatology, 3(1), 35-36. https://www.europub.co.uk/articles/-A-298455